help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deckers, M. M. L.
Right arrow Articles by Löwik, C. W. G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deckers, M. M. L.
Right arrow Articles by Löwik, C. W. G. M.
Endocrinology Vol. 141, No. 5 1667-1674
Copyright © 2000 by The Endocrine Society

ARTICLES

Expression of Vascular Endothelial Growth Factors and Their Receptors during Osteoblast Differentiation

Martine M. L. Deckers, Marcel Karperien, Chris van der Bent, Takeyoshi Yamashita, Socrates E. Papapoulos and Clemens W. G. M. Löwik

Departments of Endocrinology and Metabolic Diseases (M.M.L.D., M.K., C.v.d.B., S.E.P., C.W.G.M.L.) and Pediatrics (M.K.), Leiden University Medical Center, 2333ZA Leiden, The Netherlands; and Pharmaceutical Research Laboratory, Kirin Brewery Co. Ltd. (T.Y.), 3 Miyahara, Takasaki, Gunma 370-12, Japan

Address all correspondence and requests for reprints to: Dr. Martine M. L. Deckers, Department of Endocrinology and Metabolic Diseases, Albinusdreef 2, Building 1 C4R-89, 2333 ZA Leiden, The Netherlands. E-mail: m.m.l.deckers{at}lumc.nl

Endochondral bone formation is regulated by systemically and locally acting growth factors. A role for vascular endothelial growth factor (VEGF) in this process has recently been proposed, because inactivation of VEGF inhibits endochondral bone formation via inhibition of angiogenesis. Despite the known effect of VEGF as specific endothelial growth factor, its effects on osteoblast differentiation have not been studied. We, therefore, examined the expression of VEGF-A, -B, -C, and -D and their receptors in a model of osteoblast differentiation using the mouse preosteoblast-like cell line KS483. Early in differentiation, KS483 cells express low levels VEGF-A, -B, and -D messenger RNA, whereas during mineralization, KS483 cells express high levels.

In addition, expression of the VEGF receptors, VEGFR1, VEGFR2, and VEGF165R/neuropilin, coincided with expression of their ligands, being maximally expressed during mineralization. VEGF-A production during osteoblast differentiation was stimulated by insulin-like growth factor I that enhances osteoblast differentiation and was inhibited by PTH-related peptide that inhibits osteoblast differentiation. Furthermore, continuous treatment of KS483 cells with recombinant human VEGF-A stimulated nodule formation.

Although treatment of KS483 cells with soluble FLT1, an agent that blocks binding of VEGF-A and -B to VEGFR1, did not inhibit nodule formation, this observation does not exclude involvement of VEGFR2 in the regulation of osteoblast differentiation. As it is known that VEGF-A, -C, and -D can act through activation of VEGFR2, other isoforms might compensate for VEGF-A loss. The expression pattern of VEGFs and their receptors shown here suggests that VEGFs play an important role in the regulation of bone remodeling by attracting endothelial cells and osteoclasts and by stimulating osteoblast differentiation.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
M. R. Saban, J. M. Backer, M. V. Backer, J. Maier, B. Fowler, C. A. Davis, C. Simpson, X.-R. Wu, L. Birder, M. R. Freeman, et al.
VEGF receptors and neuropilins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation
Am J Physiol Renal Physiol, July 1, 2008; 295(1): F60 - F72.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q. Zhang, R. Guo, Y. Lu, L. Zhao, Q. Zhou, E. M. Schwarz, J. Huang, D. Chen, Z.-G. Jin, B. F. Boyce, et al.
VEGF-C, a Lymphatic Growth Factor, Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine Mechanism
J. Biol. Chem., May 9, 2008; 283(19): 13491 - 13499.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
J. Dai and A.B.M. Rabie
VEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification
J. Dent. Res., October 1, 2007; 86(10): 937 - 950.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. T. Buijs, N. V. Henriquez, P. G.M. van Overveld, G. van der Horst, I. Que, R. Schwaninger, C. Rentsch, P. ten Dijke, A.-M. Cleton-Jansen, K. Driouch, et al.
Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer
Cancer Res., September 15, 2007; 67(18): 8742 - 8751.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
N. Shimojo, S. Jesmin, S. Zaedi, T. Otsuki, S. Maeda, N. Yamaguchi, K. Aonuma, Y. Hattori, and T. Miyauchi
Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H474 - H481.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
A. P. Hall, F. R. Westwood, and P. F. Wadsworth
Review of the Effects of Anti-Angiogenic Compounds on the Epiphyseal Growth Plate
Toxicol Pathol, February 1, 2006; 34(2): 131 - 147.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
S. Cherqui, S. M. Kurian, O. Schussler, J. A. Hewel, J. R. Yates III, and D. R. Salomon
Isolation and Angiogenesis by Endothelial Progenitors in the Fetal Liver
Stem Cells, January 1, 2006; 24(1): 44 - 54.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
G.D.M. Collett and A.E. Canfield
Angiogenesis and Pericytes in the Initiation of Ectopic Calcification
Circ. Res., May 13, 2005; 96(9): 930 - 938.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
V. van Weel, M. M.L. Deckers, J. M. Grimbergen, K. J.M. van Leuven, J. H.P. Lardenoye, R. O. Schlingemann, G. P. van Nieuw Amerongen, J. H. van Bockel, V. W.M. van Hinsbergh, and P. H.A. Quax
Vascular Endothelial Growth Factor Overexpression in Ischemic Skeletal Muscle Enhances Myoglobin Expression In Vivo
Circ. Res., July 9, 2004; 95(1): 58 - 66.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
E. Zelzer, R. Mamluk, N. Ferrara, R. S. Johnson, E. Schipani, and B. R. Olsen
VEGFA is necessary for chondrocyte survival during bone development
Development, May 1, 2004; 131(9): 2161 - 2171.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
R. L. van Bezooijen, B. A.J. Roelen, A. Visser, L. van der Wee-Pals, E. de Wilt, M. Karperien, H. Hamersma, S. E. Papapoulos, P. ten Dijke, and C. W.G.M. Lowik
Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist
J. Exp. Med., March 15, 2004; 199(6): 805 - 814.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F.-S. Wang, C.-J. Wang, Y.-J. Chen, P.-R. Chang, Y.-T. Huang, Y.-C. Sun, H.-C. Huang, Y.-J. Yang, and K. D. Yang
Ras Induction of Superoxide Activates ERK-dependent Angiogenic Transcription Factor HIF-1{alpha} and VEGF-A Expression in Shock Wave-stimulated Osteoblasts
J. Biol. Chem., March 12, 2004; 279(11): 10331 - 10337.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
H. E. Turner, A. L. Harris, S. Melmed, and J. A. H. Wass
Angiogenesis in Endocrine Tumors
Endocr. Rev., October 1, 2003; 24(5): 600 - 632.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Germani, A. Di Carlo, A. Mangoni, S. Straino, C. Giacinti, P. Turrini, P. Biglioli, and M. C. Capogrossi
Vascular Endothelial Growth Factor Modulates Skeletal Myoblast Function
Am. J. Pathol., October 1, 2003; 163(4): 1417 - 1428.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
C. Colnot, Z. Thompson, T. Miclau, Z. Werb, and J. A. Helms
Altered fracture repair in the absence of MMP9
Development, September 1, 2003; 130(17): 4123 - 4133.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Qin, P. Qiu, L. Wang, X. Li, J. T. Swarthout, P. Soteropoulos, P. Tolias, and N. C. Partridge
Gene Expression Profiles and Transcription Factors Involved in Parathyroid Hormone Signaling in Osteoblasts Revealed by Microarray and Bioinformatics
J. Biol. Chem., May 23, 2003; 278(22): 19723 - 19731.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
T. Furumatsu, Z. N. Shen, A. Kawai, K. Nishida, H. Manabe, T. Oohashi, H. Inoue, and Y. Ninomiya
Vascular Endothelial Growth Factor Principally Acts as the Main Angiogenic Factor in the Early Stage of Human Osteoblastogenesis
J. Biochem., May 1, 2003; 133(5): 633 - 639.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
E. Zelzer, W. McLean, Y.-S. Ng, N. Fukai, A. M. Reginato, S. Lovejoy, P. A. D'Amore, and B. R. Olsen
Skeletal defects in VEGF120/120 mice reveal multiple roles for VEGF in skeletogenesis
Development, March 6, 2003; 129(8): 1893 - 1904.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Maeda, T. Kawane, and N. Horiuchi
Statins Augment Vascular Endothelial Growth Factor Expression in Osteoblastic Cells via Inhibition of Protein Prenylation
Endocrinology, February 1, 2003; 144(2): 681 - 692.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. Gurlek, M. R. Pittelkow, and R. Kumar
Modulation of Growth Factor/Cytokine Synthesis and Signaling by 1{alpha},25-Dihydroxyvitamin D3: Implications in Cell Growth and Differentiation
Endocr. Rev., December 1, 2002; 23(6): 763 - 786.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Street, M. Bao, L. deGuzman, S. Bunting, F. V. Peale Jr., N. Ferrara, H. Steinmetz, J. Hoeffel, J. L. Cleland, A. Daugherty, et al.
Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover
PNAS, July 23, 2002; 99(15): 9656 - 9661.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. M. L. Deckers, R. L. van Bezooijen, G. van der Horst, J. Hoogendam, C. van der Bent, S. E. Papapoulos, and C. W. G. M. Lowik
Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A
Endocrinology, April 1, 2002; 143(4): 1545 - 1553.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Akeno, J. Robins, M. Zhang, M. F. Czyzyk-Krzeska, and T. L. Clemens
Induction of Vascular Endothelial Growth Factor by IGF-I in Osteoblast-Like Cells Is Mediated by the PI3K Signaling Pathway through the Hypoxia-Inducible Factor-2{alpha}
Endocrinology, February 1, 2002; 143(2): 420 - 425.
[Abstract] [Full Text] [PDF]

Home page
 Cell Growth Differ.Home page
G. R. Beck Jr., B. Zerler, and E. Moran
Gene Array Analysis of Osteoblast Differentiation
Cell Growth Differ., February 1, 2001; 12(2): 61 - 83.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
K. Pavelock, K. M. Braas, L'H. Ouafik, G. Osol, and V. May
Differential Expression and Regulation of the Vascular Endothelial Growth Factor Receptors Neuropilin-1 and Neuropilin-2 in Rat Uterus
Endocrinology, February 1, 2001; 142(2): 613 - 622.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society